The aim of the current report is to provide guidance relevant to psychological evaluation for healthcare providers and researchers working in the field of disorders of sexual development (DSD). In doing so, we give careful consideration to methodological issues and limitations that may influence the utility of investigations. For example, rarity and heterogeneity of DSD conditions restrict sample sizes when conducting evaluations aimed at establishing condition-specific psychological outcomes. At the same time, the potential for stigmatization by virtue of conducting psychological evaluations is particularly high given the fundamental contribution of sex and gender to one's sense of self and integrity. This article will provide basic theory for psychological evaluation as well as give a review of specific measures that can be employed for clinical purposes depending on a variety of parameters, including life stage of the patient and goal(s) of the evaluation. Care providers and service users may benefit from guidance in coping with the difficulties inherent in having and/or treating DSD. The potential for identification with the patient with DSD is higher than in other domains of medicine because sexual and gender identities are fundamental to all humans and are continually evolving from a sociological perspective.

1.
Abidin RR: Parenting Stress Index-Short Form (Pediatric Psychology Press, Charlottesville 1990).
2.
Achenbach TM: Empirically Based Taxonomy: How to Use Syndromes and Profile Types Derived From the CBCL/4-18, TRF, and YSR (Department of Psychiatry, University of Vermont, Burlington 1993).
3.
Achenbach TM: Manual for the Young Adult Self-Report and Young Adult Behavior Checklist (Department of Psychiatry, University of Vermont, Burlington 1997).
4.
Alpern AN, Gardner M, Kogan B, Sandberg DE, Quittner AL: Development of health-related quality of life instruments for young children with disorders of sex development (DSD) and their parents. J Pediatr Psychol 42:544-558 (2017).
5.
Balsamo A, Ghirri P, Bertelloni S, Scaramuzzo RT, D'Alberton F, et al: Disorders of Sexual Development in Newborns, in Neonatology: A Practical Approach to Neonatal Diseases, pp 1-24 (Springer, New York 2016).
6.
Beck AT, Epstein N, Brown G, Steer RA: An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893-897 (1988).
7.
Beck AT, Steer RA, Brown G: Beck depression inventory-II. San Antonio 78:490-498. (1996).
8.
Bennecke E, Werner-Rosen K, Thyen U, Kleinemeier E, Lux A, et al: Subjective need for psychological support (psysupp) in parents of children and adolescents with disorders of sex development (DSD). Eur J Pediatr 10:1287-1297 (2015).
9.
Brinkmann L, Schuetzmann K, Richter-Appelt H: Gender assignment and medical history of individuals with different forms of intersexuality: evaluation of medical records and the patients' perspective. J Sex Med 4:964-980 (2007).
10.
Browne WV, Hindmarsh PC, Pasterski V, Hughes IA, Acerini CL, et al: Working memory performance is reduced in children with congenital adrenal hyperplasia. Horm Behav 67:83-88 (2015).
11.
Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, et al: Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 5:365-376 (2013).
12.
Callens N, van der Zwan YG, Drop SL, Cools M, Beerendonk CM, et al: Do surgical interventions influence psychosexual and cosmetic outcomes in women with disorders of sex development? ISRN Endocrinol 2012:276742 (2012a).
13.
Callens N, De Cuypere G, Wolffenbuttel KP, Beerendonk C, van der Zwan YG, et al: Long-term psychosexual and anatomical outcome after vaginal dilation or vaginoplasty: a comparative study. J Sex Med 7:1842-1851 (2012b).
14.
Callens N, Weyers S, Monstrey S, Stockman S, Van Hoorde B, et al: Vaginal dilation treatment in women with vaginal hypoplasia: a prospective one-year follow-up study. Am J Obstet Gynecol 211:228.e1-228.e12 (2014).
15.
Callens N, van Kuyk M, van Kuppenveld JH, Drop SL, Cohen-Kettenis PT, et al: Recalled and current gender role behavior, gender identity and sexual orientation in adults with disorders/differences of sex development. Horm Behav 86:8-20 (2016).
16.
Cohen-Kettenis P: Psychosocial and psychosexual aspects of disorders of sex development. Best Pract Res Clin Endocrinol Metab 2:325-334 (2010).
17.
Cohen-Kettenis PT, Wallien M, Johnson LL, Owen-Anderson AF, Bradley SJ, Zucker KJ: A parent-report gender identity questionnaire for children: a cross-national, cross-clinic comparative analysis. Clin Child Psychol Psychiatry 3:397-405 (2006).
18.
Collaer ML, Hindmarsh PC, Pasterski V, Fane BA, Hines M: Reduced short term memory in congenital adrenal hyperplasia (CAH) and its relationship to spatial and quantitative performance. Psychoneuroendocrinology 64:164-173 (2016).
19.
Creamer M, Bell R, Failla S: Psychometric properties of the impact of event scale -revised. Behav Res Ther 12:1489-1496 (2003).
20.
Crissman HP, Warner L, Gardner M, Carr M, Schast A, et al: Children with disorders of sex development: A qualitative study of early parental experience. Int J Pediatr Endocrinol 2011:10 (2011).
21.
D'Alberton F: Disclosing disorders of sex development and opening the doors. Sex Dev 4-5:304-309 (2010).
22.
D'Alberton F, Assante MT, Foresti M, Balsamo A, Bertelloni S, et al: Quality of life and psychological adjustment of women living with 46,XY differences of sex development. J Sex Med 6:1440-1449 (2015).
23.
De Silva K, de Zoysa P, Dilanka W, Dissanayake B: Psychological impact on parents of children with congenital adrenal hyperplasia: a study from Sri Lanka. J Pediatr Endocrinol Metab 5-6: 475-478 (2014).
24.
Derogatis LR: SCL-90-R: Administration, Scoring & Procedures Manual-II for the R (evised) Version and Other Instruments of the Psychopathology Rating Scale Series (Clinical Psychometric Research, Baltimore 1992).
25.
Derogatis LR, Spencer P: Brief Symptom Inventory: BSI (Pearson, Upper Saddle River 1993).
26.
Derogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y: Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2:357-364 (2008).
27.
Dessens AB, Slijper FM, Drop SL: Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav 4:389-397 (2005).
28.
de Vries AL, Steensma TD, Cohen-Kettenis PT, VanderLaan DP, Zucker KJ: Poor peer relations predict parent-and self-reported behavioral and emotional problems of adolescents with gender dysphoria: a cross-national, cross-clinic comparative analysis. Eur Child Adolesc Psychiatry 6:579-588 (2016).
29.
Diener E, Emmons RA, Larsen RJ, Griffin S: The satisfaction with life scale. J Pers Assess 1:71-75 (1985).
30.
Eggers S, Ohnesorg T, Sinclair A: Genetic regulation of mammalian gonad development. Nat Rev Endocrinol 11:673-683 (2014).
31.
Feldman PJ, Dunkel-Schetter C, Sandman CA, Wadhwa PD: Maternal social support predicts birth weight and fetal growth in human pregnancy. Psychosom Med 5:715-725 (2000).
32.
Fliegner M, Krupp K, Brunner F, Rall K, Brucker SY, et al: Sexual life and sexual wellness in individuals with complete androgen insensitivity syndrome (CAIS) and Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS). J Sex Med 3:729-742 (2014).
33.
Goodman R: The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry 5:581-586 (1997).
34.
Hardt J, Rutter M: Validity of adult retrospective reports of adverse childhood experiences: review of the evidence. J Child Psychol Psychiatry 2:260-273 (2004).
35.
Helmreich RL, Spence JT, Wilhelm JA: A psychometric analysis of the personal attributes questionnaire. Sex Roles 11:1097-1108 (1981).
36.
Helsel WJ, Matson JL: The assessment of depression in children: the internal structure of the child depression inventory (CDI). Behav Res Therapy 3:289-298 (1984).
37.
Hernán MA, Hernández-Díaz S, Robins JM: A structural approach to selection bias. Epidemiology 5:615-625 (2004).
38.
Hines M: Gender development and the human brain. Annu Rev Neurosci 34:69-88 (2011).
39.
Hines M, Pasterski V, Spencer D, Neufeld S, Patalay P, et al: Prenatal androgen exposure alters girls' responses to information indicating gender-appropriate behaviour. Philos Trans R Soc Lond B Biol Sci 371:20150125 (2016).
40.
Hiort O, Birnbaum W, Marshall L, Wünsch L, Werner R, et al: Management of disorders of sex development. Nat Rev Endocrinol 9:520-529 (2014).
41.
Houk CP, Hughes IA, Ahmed SF, Lee PA: Summary of consensus statement on intersex disorders and their management. International intersex consensus conference. Pediatrics 2:753-757 (2006).
42.
Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis P: Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development. Best Pract Res Clin Endocrinol Metab 3:351-365 (2007).
43.
Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannoloulou K, MacDougall J: Androgen insensitivity syndrome. Lancet 380:1419-1428 (2012).
44.
Ivanova MY, Achenbach TM, Rescorla LA, Dumenci L, Almqvist F, et al: The generalizability of the youth self-report syndrome structure in 23 societies. J Consult Clin Psychology 5:729 (2007).
45.
Kyriakou A, Dessens A, Bryce J, Iotova V, Juul A, et al: Current models of care for disorders of sex development - results from an international survey of specialist centres. J Rare Dis 11:155 (2016).
46.
Karkazis K: Fixing Sex: Intersex, Medical Authority, and Lived Experience (Duke University Press, Durham 2008).
47.
Lee PA, Houk CP, Ahmed SF, Hughes IA: Consensus statement on management of intersex disorders. International consensus conference on intersex. Pediatrics 2:e488-e500 (2006).
48.
Leithner K, Naderer A, Hartung D, Abrahamowicz C, Alexopoulos J, et al: Sexual and psychosocial functioning in women with MRKHS after neovaginoplasty according to Wharton-Sheares-George: a case control study. PLoS One 4:e0124604 (2015).
49.
Liao LM, Green H, Creighton S, Crouch N, Conway G: Service users' experiences of obtaining and giving information about disorders of sex development. BJOG 2:193-199 (2010).
50.
Liao LM, Baker E, Boyle M, Woodhouse C, Creighton S: Experiences of surgical continence management approaches for cloacal anomalies: a qualitative analysis based on 6 women. J Pediatr Adolesc Gynecol 5:266-270 (2014).
51.
Lichtman M: Qualitative Research for the Social Sciences (Sage Publications, Los Angeles 2013).
52.
Lucas-Herald A, Bertelloni S, Juul A, Bryce J, Jiang J, et al: The long-term outcome of boys with partial androgen insensitivity syndrome and a mutation in the androgen receptor gene. J Clin Endocrinol Metab 11:3959-3967 (2016).
53.
Lundberg T, Roen K, Hirschberg AL, Frisén L: “It's part of me, not all of me”: Young women's experiences of receiving a diagnosis related to diverse sex development. J Pediatr Adolesc Gynecol 4:338-343 (2016).
54.
Malouf MA, Inman AG, Carr AG, Franco J, Brooks LM: Health-related quality of life, mental health and psychotherapeutic considerations for women diagnosed with a disorder of sexual development: Congenital adrenal hyperplasia. Int J Pediatr Endocrinol 1:253465 (2010).
55.
Menke LA, Sas TC, Visser M, Kreukels BP, Stijnen T, et al: The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome. Horm Behav 3:297-305 (2010).
56.
Meyer-Bahlburg HF: Gender identity outcome in female-raised 46,XY persons with penile agenesis, cloacal exstrophy of the bladder, or penile ablation. Arch Sex Behav 34:423-438 (2005).
57.
Meyer-Bahlburg HF: From mental disorder to iatrogenic hypogonadism: dilemmas in conceptualizing gender identity variants as psychiatric conditions. Arch Sex Behav39:461-476 (2010).
58.
Meyer-Bahlburg HF, Dolezal C, Baker SW, Ehrhardt AA, New MI: Gender development in women with congenital adrenal hyperplasia as a function of disorder severity. Arch Sex Behav 35:667-684 (2006).
59.
Morris JM: The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol 6:1192-1211 (1953).
60.
Mouriquand PD, Gorduza DB, Gay CL, Meyer-Bahlburg HF, Baker L, et al: Surgery in disorders of sex development (DSD) with a gender issue: If (why), when, and how? J Pediatr Urol 3:139-149 (2016).
61.
Nokoff NJ, Palmer B, Mullins AJ, Aston CE, Austin P, et al: Prospective assessment of cosmesis before and after genital surgery. J Pediatr Urol 13:28.e1-28.e6 (2017).
62.
Nermoen I, Husebye ES, Svartberg J, Løvås K: Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur J Endocrinol 3:453-459 (2010).
63.
Ono M, Harley VR: Disorders of sex development: new genes, new concepts. Nat Rev Endocrinol 2:79-91 (2013).
64.
Pasterski V, Hindmarsh P, Geffner M, Brook C, Brain C, Hines M: Increased aggression and activity level in 3- to 11-year-old girls with congenital adrenal hyperplasia (CAH). Horm Behav 3:368-374 (2007).
65.
Pasterski V, Prentice P, Hughes IA: Consequences of the Chicago consensus on disorders of sex development (DSD): current practices in Europe. Arch Dis Child 8:618-623 (2010a).
66.
Pasterski V, Prentice P, Hughes IA: Impact of the consensus statement and the new DSD classification system. Best Pract Res Clin Endocrinol Metab 2:187-195 (2010b).
67.
Pasterski V, Geffner ME, Brain C, Hindmarsh P, Brook C, Hines M: Prenatal hormones and childhood sex segregation: playmate and play style preferences in girls with congenital adrenal hyperplasia. Horm Behav 4:549-555 (2011).
68.
Pasterski V, Mastroyannopoulou K, Wright D, Zucker KJ, Hughes IA: Predictors of posttraumatic stress in parents of children diagnosed with a disorder of sex development. Arch Sex Behav 2:369-375 (2014).
69.
Pasterski V, Zucker KJ, Hindmarsh PC, Hughes IA, Acerini C, et al: Increased cross-gender identification independent of gender role behavior in girls with congenital adrenal hyperplasia: results from a standardized assessment of 4-to 11-year-old children. Arch Sex Behav 5:1363-1375 (2015).
70.
Petrie TA, Tripp MM, Harvey P: Factorial and construct validity of the body parts satisfaction scale-revised: an examination of minority and nonminority women. Psychology of Women Quarterly 3:213-221 (2002).
71.
Poomthavorn P, Stargatt R, Zacharin M: Psychosexual and psychosocial functions of anorchid young adults. J Clin Endocrinol Metab 7:2502-2505 (2009).
72.
Rieger G, Linsenmeier JA, Gygax L, Bailey JM: Sexual orientation and childhood gender nonconformity: evidence from home videos. Dev Psychol 1:46 (2008).
73.
Roen K, Pasterski V: Psychological research and intersex/DSD: recent developments and future directions. Psychol Sex 1:102-116 (2014).
74.
Ros C, Alobid I, Balasch J, Mullol J, Castelo-Branco C: Turner's syndrome and other forms of congenital hypogonadism impair quality of life and sexual function. Am J Obstet Gynecol 208:484 (2013).
75.
Rosen CB, Heiman J, Leiblum S, Meston C, Shabsigh R, et al: The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2:191-208 (2000).
76.
Rosen RC, Catania J, Pollack L, Althof S, O'Leary M, Seftel AD: Male sexual health questionnaire (MSHQ): scale development and psychometric validation. Urology 4:777-782 (2004).
77.
Rosenberg M: Society and the Adolescent Self-Image (Princeton University Press Princeton 1965).
78.
Sanders C, Edwards Z, Keegan K: Exploring stakeholder experiences of interprofessional teamwork in sex development outpatient clinics. J Interprof Care 31:376-385 (2017).
79.
Schober J, Nordenström A, Hoebeke P, Lee P, Houk C, et al: Disorders of sex development: summaries of long-term outcome studies. J Pediatr Urol 6:616-623 (2012).
80.
Scholte RH, De Bruyn EE: The revised junior Eysenck personality questionnaire (JEPQ-R): Dutch replications of the full-length, short, and abbreviated forms. Personal Individ Differ 4:615-625 (2001).
81.
Schützmann K, Brinkmann L, Schacht M, Richter-Appelt H: Psychological distress, self-harming behavior, and suicidal tendencies in adults with disorders of sex development. Arch Sex Behav 38:16-33 (2009).
82.
Schweizer K, Brunner F, Gedrose B, Handford C, Richter-Appelt H: Coping with diverse sex development: treatment experiences and psychosocial support during childhood and adolescence and adult well-being. J Pediatr Psychol 42:504-519 (2016).
83.
Snell WE, Fisher TD, Miller RS: Development of the sexual awareness questionnaire: components, reliability, and validity. Ann Sex Res 1:65-92 (1991).
84.
Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, et al: Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95:4133-4160 (2010).
85.
Spielberger CD: State-Trait Anxiety Inventory (Wiley Online Library 2010).
86.
Strandqvist A, Falhammar H, Lichtenstein P, Hirschberg A, Wedell A, et al: Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden. J Clin Endocrinol Metab 4:1425-1432 (2014).
87.
Suorsa KI, Mullins AJ, Tackett AP, Reyes KJS, Austin P, et al: Characterizing early psychosocial functioning of parents of children with moderate to severe genital ambiguity due to disorders of sex development. J Urol 6:1737-1742 (2015).
88.
Tiryaki S, Tekin A, Yağmur İ, Özen S, Özbaran B, et al: Parental view on the terminology of disorders of sex development. J Clin Res Pediatr Endocrinol 9:1 (2017).
89.
Wolfe-Christensen C, Fedele DA, Kirk K, Phillips TM, Mazur T, et al: Degree of external genital malformation at birth in children with a disorder of sex development and subsequent caregiver distress. J Urol 4:1596-1600 (2012).
90.
Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA: Psychometric characteristics of the multidimensional scale of perceived social support. J Pers Assess 55:610-617 (1990).
91.
Zucker KJ, Bradley SJ, Sullivan CBL, Kuksis M, Birkenfeld-Adams A, Mitchell JN: A gender identity interview for children. J Pers Assess 61:443-456 (1993).
92.
Zucker KJ, Mitchell JN, Bradley SJ, Tkachuk J, Cantor JM, Allin SM: The recalled childhood gender identity/gender role questionnaire: psychometric properties. Sex Roles 54:469-483 (2006).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.